To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
AGIC enters US market with pharma deal
The European-Asian fund has sealed its first US deal, the fourth investment from its $1 billion debut fund.
